Leblanc, Olivia <br/><br/>
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.  [electronic resource] 

 -  Cancer biology & medicine  02 2020 
 - 208-217 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2095-3941 
<br/><br/><label>Standard No.: </label>10.20892/j.issn.2095-3941.2019.0153  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--analysis<br/>Cetuximab--pharmacology<br/>Class I Phosphatidylinositol 3-Kinases--genetics<br/>DNA Mutational Analysis<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Follow-Up Studies<br/>Gain of Function Mutation<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Progression-Free Survival<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Squamous Cell Carcinoma of Head and Neck--drug therapy